Lv1
60 积分 2023-09-17 加入
A phase Ib study of safety and preliminary efficacy of extracranial stereotactic body radiation therapy (SBRT) in patients with metastatic renal cell carcinoma (mRCC) treated with systemic therapy
21小时前
待确认
Ablation of a Site of Progression With Stereotactic Body Radiation Therapy Extends Sunitinib Treatment From 14 to 22 Months
21小时前
已关闭
50: Prospective Neurocognitive Functions of Patients Treated with Concurrent Nivolumab and Stereotactic Brain Radiosurgery for NSCLC and RCC Brain Metastases
21小时前
已完结
Outcomes of Targeted Therapy Plus Immunotherapy and High-Dose Stereotactic Ablative Body Radiotherapy (SABR) for Metastatic Renal Cell Cancer Patients
21小时前
已完结
Phase II clinical study of the safety and efficacy of sintilimab in combination with axitinib and stereotactic radiotherapy in the treatment of local-regional recurrent renal cell cancer
21小时前
已关闭
PO-1575 A phase II trial of PRaG regimens rechallenge for PD-1 inhibitor resistance in advanced tumors
23小时前
待确认
Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
23小时前
已完结
Effectiveness of pazopanib and SBRT in metastatic renal cell carcinoma
23小时前
已关闭
Nivolumab without brain radiotherapy is insufficient for the treatment of most patients with brain metastases from clear cell renal cell carcinoma
23小时前
已完结
OC-0060 I-SABR induces local and abscopal responses in metastatic patients after failure to ICI treatment
1天前
已关闭
皖公网安备34019202002308
